MALARIA RESEARCH INSTITUTE
Leading Science for a Malaria-Free World
Founded in May 2001 and continuously supported by Bloomberg Philanthropies, the Johns Hopkins Malaria Research Institute conducts discovery research at the Bloomberg School of Public Health in Baltimore and field research at the Macha Research Trust in Zambia and other sites of endemic malaria in sub-Saharan Africa, India, and elsewhere.
The initial Bloomberg Philanthropies gift established a state-of-the-art research facility with the goal to treat and control malaria, develop a vaccine, and find new drug targets and innovative strategies to prevent and cure the deadly disease. The Institute has contributed to advances in all these areas and is one of the most comprehensive research endeavors focused on malaria globally.
Vector Encounter 2025
Join us in Baltimore on Thursday, June 5 - Friday, June 6. Learning and networking abound. Registration is now OPEN through May 27, 2025.
News
A Rare Mosquito-Borne Illness Is On The Rise. Here's What To Know. Matthew Ippolito, MD, is quoted.
Rare, deadly mosquito disease is causing alarm in New England. But how risky is "triple E" virus? David Sullivan, MD, is quoted.
Why Mosquitoes Are So Dangerous Right Now. Photini Sinnis, MD, is quoted.
New Research
Assembled genome of an Ethiopian Plasmodium vivax isolate generated using GridION long-read technology | Carlton Lab
Application of Machine Learning in a Rodent Malaria Model for Rapid, Accurate, and Consistent Parasite Counts | Srinivasan Lab
The major surface protein of malaria sporozoites is GPI-anchored to the plasma membrane | Sinnis Lab
130+
Pilot grants awarded
750+
First- and last-authored publications since 2010